Compare PTCT & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | AROC |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.5B |
| IPO Year | 2006 | 2007 |
| Metric | PTCT | AROC |
|---|---|---|
| Price | $72.08 | $37.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $80.65 | $40.00 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | ★ 264.48 | 74.29 |
| EPS | N/A | ★ 0.41 |
| Revenue | $264,734,000.00 | ★ $1,489,818,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $17.70 | $5.27 |
| P/E Ratio | ★ N/A | $90.62 |
| Revenue Growth | ★ 36.19 | 28.70 |
| 52 Week Low | $43.18 | $21.17 |
| 52 Week High | $87.50 | $40.12 |
| Indicator | PTCT | AROC |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 51.90 |
| Support Level | $61.59 | $34.30 |
| Resistance Level | $79.67 | $40.12 |
| Average True Range (ATR) | 3.55 | 1.37 |
| MACD | 0.59 | -0.22 |
| Stochastic Oscillator | 49.85 | 32.74 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.